|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.68 USD | -1.42% |
|
-2.47% | +3.13% |
| 05-09 | Ireland's fiscal success faces the risk of over-reliance |  |
| 05-06 | CellCentric Ltd announced that it has received $220 million in funding from a group of investors | CI |
| Capitalization | 146B 124B 114B 107B 200B 13,823B 202B 1,350B 526B 6,640B 549B 538B 22,923B | P/E ratio 2026 * |
12x | P/E ratio 2027 * | 12.6x |
|---|---|---|---|---|---|
| Enterprise value | 195B 165B 151B 143B 266B 18,382B 269B 1,795B 700B 8,830B 730B 715B 30,484B | EV / Sales 2026 * |
3.16x | EV / Sales 2027 * | 3.18x |
| Free-Float |
59.05% | Yield 2026 * |
6.82% | Yield 2027 * | 6.79% |
Last Transcript: Pfizer Inc.
| 1 day | -1.42% | ||
| 1 week | -2.47% | ||
| Current month | -3.82% | ||
| 1 month | -4.61% | ||
| 3 months | -6.99% | ||
| 6 months | +5.29% | ||
| Current year | +3.13% |
| 1 week | 25.6 |  | 26.75 |
| 1 month | 25.6 | | 27.84 |
| Current year | 24.83 | | 28.74 |
| 1 year | 21.97 | | 28.74 |
| 3 years | 20.92 | | 40.36 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 01/01/2019 |
David Denton
DFI | Director of Finance/CFO | 61 | 02/05/2022 |
| Chief Tech/Sci/R&D Officer | - | 01/01/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 01/09/2007 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 27/09/2013 |
Albert Bourla
CHM | Chairman | 64 | 01/01/2020 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.75% | 9.37% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.42% | -2.47% | +15.26% | -32.95% | 146B | |
| -2.72% | -1.54% | +29.12% | +117.57% | 846B | |
| -0.53% | -2.58% | +43.51% | +36.91% | 533B | |
| -0.57% | -2.44% | +9.18% | +37.65% | 356B | |
| -0.94% | -0.97% | +22.40% | +12.53% | 324B | |
| +0.23% | -1.24% | +30.31% | +12.89% | 282B | |
| +0.05% | -2.19% | +24.69% | +23.30% | 278B | |
| -0.82% | -0.70% | +46.61% | -5.53% | 275B | |
| -1.76% | +4.42% | -34.66% | -49.14% | 203B | |
| +0.79% | +0.57% | +24.76% | +41.69% | 179B | |
| Average | -0.77% | -0.85% | +21.12% | +19.49% | 342.17B | |
| Weighted average by Cap. | -1.07% | -1.22% | +25.19% | +40.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.67B 52.39B 47.95B 45.26B 84.42B 5,824B 85.16B 569B 222B 2,798B 231B 226B 9,658B | 59.36B 50.43B 46.16B 43.57B 81.26B 5,606B 81.98B 548B 213B 2,693B 223B 218B 9,297B |
| Net income | 11.05B 9.39B 8.59B 8.11B 15.13B 1,044B 15.26B 102B 39.73B 501B 41.46B 40.59B 1,731B | 11.11B 9.44B 8.64B 8.16B 15.21B 1,050B 15.35B 103B 39.96B 504B 41.69B 40.82B 1,741B |
| Net Debt | 48.27B 41.01B 37.53B 35.43B 66.08B 4,559B 66.67B 445B 174B 2,190B 181B 177B 7,561B | 42.16B 35.82B 32.78B 30.94B 57.71B 3,982B 58.22B 389B 152B 1,913B 158B 155B 6,603B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/05/26 | 25.68 $ | -3.02% | 38,903,356 |
| 07/05/26 | 26.48 $ | -0.19% | 48,345,971 |
| 06/05/26 | 26.53 $ | +0.30% | 40,357,069 |
| 05/05/26 | 26.45 $ | +0.57% | 57,656,105 |
| 04/05/26 | 26.30 $ | -0.11% | 34,583,353 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition